Brudno, J.N., Kovkenderfer, J.N., Toxicities of chimeric antigen receptor T cells: recognition and management. Blood 127 (2016), 3321–3330.
Alvi, R.M., Frigault, M.J., Fradeley, M.G., et al. Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T). J Am Coll Cardiol 74 (2019), 3099–3108.
Liu, D., Zhao, J., Cytokine release syndrome: grading, modeling, and new therapy. J Hematol Oncol, 11, 2018, 121.
Le, R.Q., Li, L., Yuan, W., et al. FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome. Oncologist 23 (2018), 943–947.
Lancellotti, P., Suter, T.M., Lopez-Fernandez, T., et al. Cardio-oncology service: rationale, organization, and implementation. Eur Heart J 40 (2019), 1756–1763.